Repositioning Drugs for Psychiatry.
作者信息
Akhondzadeh Shahin
机构信息
Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Avicenna J Med Biotechnol. 2020 Apr-Jun;12(2):67.
Abstract
摘要
相似文献
1
Repositioning Drugs for Psychiatry.重新定位用于精神科的药物。
Avicenna J Med Biotechnol. 2020 Apr-Jun;12(2):67.
2
Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data.精神分裂症和抑郁/焦虑障碍的药物重定位：利用表达数据的机器学习方法。
IEEE J Biomed Health Inform. 2019 May;23(3):1304-1315. doi: 10.1109/JBHI.2018.2856535. Epub 2018 Jul 16.
3
Drug repositioning for enzyme modulator based on human metabolite-likeness.基于人类代谢物相似性的酶调节剂药物重新定位。
BMC Bioinformatics. 2017 May 31;18(Suppl 7):226. doi: 10.1186/s12859-017-1637-5.
4
[Development of a Novel Treatment for Neurological Disorders by Drug Repositioning].[通过药物重新定位开发神经疾病的新型治疗方法]
Brain Nerve. 2019 Sep;71(9):936-942. doi: 10.11477/mf.1416201385.
5
Network mirroring for drug repositioning.用于药物重新定位的网络镜像
BMC Med Inform Decis Mak. 2017 May 18;17(Suppl 1):55. doi: 10.1186/s12911-017-0449-x.
6
Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.药物在心脏代谢紊乱中的重新定位：重要性与现状
Curr Top Med Chem. 2016;16(19):2189-200. doi: 10.2174/1568026616666160216152138.
7
Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events.基于网络的药物重新定位机会：寻找具有低血压不良事件的潜在抗高血压药物。
J Med Internet Res. 2016 Apr 1;18(4):e76. doi: 10.2196/jmir.4541.
8
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.卵巢癌药物重定位的现状和展望。
J Gynecol Oncol. 2019 Jan;30(1):e10. doi: 10.3802/jgo.2019.30.e10. Epub 2018 Oct 10.
9
Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.利用社交媒体数据进行药物重新定位以加速药物开发：帕金森病的计算研究
J Med Internet Res. 2018 Oct 11;20(10):e271. doi: 10.2196/jmir.9646.
10
Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.从社交媒体和制药数据库中提取的表型信息挖掘异构网络进行药物重定位。
Artif Intell Med. 2019 May;96:80-92. doi: 10.1016/j.artmed.2019.03.003. Epub 2019 Mar 9.
引用本文的文献
1
Topiramate and other kainate receptor antagonists for depression: A systematic review of randomized controlled trials.托吡酯和其他 kainate 受体拮抗剂治疗抑郁症：随机对照试验的系统评价。
Neuropsychopharmacol Rep. 2022 Dec;42(4):421-429. doi: 10.1002/npr2.12284. Epub 2022 Aug 1.
本文引用的文献
1
Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing.精神分裂症的抗炎策略：治疗应用及药物重新利用的证据综述
Clin Psychopharmacol Neurosci. 2020 Feb 29;18(1):10-24. doi: 10.9758/cpn.2020.18.1.10.
2
Impact of Precision Medicine on Drug Repositioning and Pricing: A Too Small to Thrive Crisis.精准医学对药物重新定位和定价的影响：规模过小难以蓬勃发展的危机
J Pers Med. 2018 Nov 5;8(4):36. doi: 10.3390/jpm8040036.
3
Drug repositioning and repurposing: terminology and definitions in literature.药物重新定位与用途拓展：文献中的术语及定义
Drug Discov Today. 2015 Aug;20(8):1027-34. doi: 10.1016/j.drudis.2015.05.001. Epub 2015 May 11.
4
Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.口服东莨菪碱增强治疗中重度抑郁症：一项随机、双盲、安慰剂对照研究。
J Clin Psychiatry. 2012 Nov;73(11):1428-33. doi: 10.4088/JCP.12m07706. Epub 2012 Oct 16.
5
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.塞来昔布添加治疗对伴有抑郁症患者症状和血清 IL-6 浓度的影响：一项随机双盲安慰剂对照研究。
J Affect Disord. 2012 Dec 10;141(2-3):308-14. doi: 10.1016/j.jad.2012.03.033. Epub 2012 Apr 18.
6
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.米氮平添加治疗对利培酮治疗精神分裂症的效果：一项双盲随机安慰剂对照试验。
Schizophr Res. 2010 Feb;116(2-3):101-6. doi: 10.1016/j.schres.2009.11.008. Epub 2009 Dec 2.
7
The 5-HT hypothesis of schizophrenia.精神分裂症的5-羟色胺假说。
IDrugs. 2001 Mar;4(3):295-300.
Zotero 插件